RGC

REGENCELL BIOSCIENCE HLDGS L

RGC·G7487R100·US·Common Stock·Healthcare - Drug Manufacturers - Specialty & Generic-Activist

RGC (REGENCELL BIOSCIENCE HLDGS L) is held by 25 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($2.6M), Alyeska Investment Group, L.P. ($2.5M), Legal & General Group Plc ($778,974). Net institutional sentiment: Mixed.

25
Holders
$8.4M
Total Value
61% (31)
Consensus
19 buying - 12 selling
13F: Insider & Congress: Updated regularly
RGC

Smart Money Verdict

View all
Loading verdict
Held by 25 funds

Who's Trading

Source dates: Price Oct 16, 2026 · Insiders none · Activists Jul 11, 2025 · Congress none

ActivistR(Regencell (BVI) Limited86.2%Jul 11, 2025

Top Holders

Checking access…
Action
Increased
422,011(+1.6%)$2.6M0.0%-42.08%
27
New
416,261$2.5M0.0%+57.47%
36
Increased
128,000(+1192.5%)$778,9740.0%+26.41%
40
New
98,348$598,9400.0%+57.47%
37
New
60,061$365,7710.0%+57.47%
33
Increased
47,159(+448.7%)$287,1980.0%-0.26%
38
Increased
43,208(+80.9%)$263,1370.0%-35.55%
24
New
41,750$254,2580.0%+57.47%
32
New
23,129$140,8560.0%+57.47%
34
Decreased
22,036(-17.2%)$134,1990.0%-44.34%
0
New
15,292$93,1280.0%+57.47%
30
Decreased
14,994(-12.7%)$91,3130.0%-62.27%
0
New
14,406$87,7330.0%+57.47%
30
Decreased
11,199(-62.1%)$68,2020.0%-45.67%
0
Decreased
5,052(-74.8%)$30,7680.0%-43.04%
0
Decreased
4,925(-0.7%)$29,9940.0%-41.90%
0
Increased
2,803(+25.6%)$17,0700.0%-55.36%
23
Increased
1,831(+1830x)$11,1510.0%+57.20%
19
New
1,717$10,4560.0%+57.47%
26
Increased
953(+169.2%)$5,8040.0%-27.75%
17

Showing 1-20 of 32

1 / 2
RGCRGCREGENCELL BIOSCIENCE HLDGS L

Other Healthcare stocks held by institutions

Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used